SEC Form 3 · accession 0001477932-18-001177
Cure Pharmaceutical Holding Corp. · CURR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Udell
Officer — Chief Financial Officer
Period of report
Mar 1, 2018
Accepted (ET)
Mar 8, 2018 · 4:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001643301
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 442,632 | D |
Table II — derivative securities
No Table II lines on this filing.